Delivery Order SPE2DB25D3110-SPE2DB25FTEKN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,357.43 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial pharmaceutical commonly used for malaria prevention and treatment in military personnel. The contract was executed on July 14, 2025, with an ultimate completion date of July 15, 2025, and represents a firm fixed-price, non-set-aside competitive award. Performance will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,040.63 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100s, a pharmaceutical product used for malaria prophylaxis and treatment. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $4,963.64 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The pharmaceutical product is an antimalarial medication commonly used for malaria prevention and...
- The Defense Logistics Agency awarded a $22,386 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used by military personnel for malaria prophylaxis. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-competitive award under the company's existing indefinite delivery contract with DLA. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units) with a ceiling value of $6,804.82. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. The order has an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.35 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial medication will support federal medical supply requirements, likely for military personnel...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,343.16 on September 9, 2025, for Atovaquone-Proguanil 250-100 (100 tablets), with a completion date of September 10, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply needs. The order...
- The Defense Logistics Agency awarded a delivery order valued at $3,469.83 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg in 100-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication delivery supports federal medical procurement requirements, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,913.94 for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used for malaria prophylaxis and treatment in military and veteran populations. This firm fixed-price delivery order, awarded July 10, 2025, with completion scheduled for July 11, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEKNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,673.47 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100, a pharmaceutical product typically used for malaria prevention and treatment. The contract was awarded on September 16, 2025, with a completion date of September 17, 2025, and employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and medical devices across multiple therapeutic domains. The arrangement supports critical medical procurement for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 9/16/25 |